Assessment of CURB-65, Quick-SOFA and Charlson Index in the prediction of mortality and Long of Stay in patients with Acquired-community Pneumonia

Evaluación de índices CURB-65, Quick-SOFA e índice de Charlson en la predicción de mortalidad y estancia hospitalaria en pacientes con neumonía adquirida en la comunidad

Published 2018-11-13

Open | Download
PDF (Spanish) FLIP
Issue
Vol. 30 No. 1 (2018)
Section
Research article
How to Cite
Assessment of CURB-65, Quick-SOFA and Charlson Index in the prediction of mortality and Long of Stay in patients with Acquired-community Pneumonia.
rev. colomb. neumol. [Internet]. 2018 Nov. 13 [cited 2024 Nov. 23];30(1):7-17. Disponible en: https://doi.org/10.30789/rcneumologia.v30.n1.2018.297
DOI

https://doi.org/10.30789/rcneumologia.v30.n1.2018.297
Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Yardany Rafael Méndez Fandiño
    Edgar Yaset Caicedo Ochoa
      Nury Alexandra Amaya
        Jorge Andrés Urrutia Gómez
          Adriana Sofía Ayala
            Show authors biography

            INTRODUCTION: Acquired-community pneumonia (ACP) is a main infectious disease that affect in geriatric people, and, might be potentially a cause of mortality associated to develop pulmonary sepsis. The present study has as objective assessment CURB-65, q-SOFA and Charlson Indexes in the association with Mortality and Long Stay in patient with ACP.
            MATERIALS AND METHODS: We realized an observational, analytic, retrospective study, in the Regional of Duitama Hospital on June-December of 2016. We selected patients with clinic, paraclinic and radiology diagnostic of ACP. We evaluate variables demographics, comorbidities, clinic conditions and outcomes of mortality, long of stay and use of broad antibiotic according to CURB-65, q-SOFA and Charlson Indexes.
            RESULTS: We recollected a sample of 116 patients. 77.5% were more 75 years. CURB-65 and q-SOFA are associated with mortality (CURB-65 AUC: 0.75 [0.61-0.88 %]; q-SOFA AUC: 0.73 [0.59-0.88]). CURB-65 ≥ 3 points have S: 64% E: 79%, and q-SOFA ≥ 2 points have S: 64% E: 85%. Charlson Index don’t have a good prediction to mortality in the management acute. The three indexes don’t associate with a good prediction with Long Stay and Use of Broad Antibiotic.
            CONCLUSIONS: The q-SOFA and CURB-65 are indexes that might use in the management acute of ACP to estimate mortality in the patient.

            Article visits 2703 | PDF visits 8996

            Downloads

            Download data is not yet available.
            1. Báez Saldaña R, Gómez Zamora C, López Elizondo C, Molina Corona H, Santillán Martínez A, Sánchez Hernández J, et al. Neumonía adquirida en la comunidad. Revisión y actualización con una perspectiva orientada a la calidad de la atención médica. Neumol Cir Torax. 2013;72(Suppl 1):6-43.
            2. Montúfar FE, Varón FA, Giraldo LF, Sáenz ÓA, Rodríguez A, Alarcón AM, et al. Recomendaciones para el diagnóstico, tratamiento y prevención de la neumonía adquirida en la comunidad en adultos inmunocompetentes. Infectio. 2013;17(Suppl 1):1-38.
            3. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med. 2001;163(7):1730-54.
            4. Comité Nacional Conjunto de Neumonía Adquirida en la Comunidad. Recomendaciones para el diagnóstico, tratamiento y prevención de la neumonía adquirida en la comunidad en adultos. Rev Colomb Neumol. 2003;15(Supl 3):S1-S42.
            5. Menéndez R, Torres A, Aspa J, Capelastegui A, Prat C, Rodríguez de Castro F, et al. Neumonía adquirida en la comunidad. Nueva normativa de la Sociedad Española de Neumología y Cirugía del Tórax (SEPAR). Arch Bronconeumol. 2010;46(10):543-58.
            6. Saldías PF, Díaz PO. Evaluación y manejo de la neumonía del adulto adquirida en la comunidad. Rev Med Clin Las Condes. 2014;25(3):553-64.
            7. Martín AA, Moreno-Pérez D, Alfayate S, et al. Etiología y diagnóstico de la neumonía adquirida en la comunidad y sus formas complicadas. An Pediatr (Barc). 2012;76(3):162-162.
            8. Don M, Canciani M, Korppi M. Community-acquired pneumonia in children: what’s old? What’s new? Acta Paediatr. 2010;99(11):1602-8.
            9. Carbonara S, Monno L, Longo B, Angarano G. Communityacquired pneumonia. Curr Opin Pulm Med. 2009;15(3):261-73.
            10. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64 Suppl 3:iii1-55.
            11. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31(2):347-82.
            12. Chelluri I, Grenvik A, Silverman M. Intensive care for critically ill elderly: mortality, cost and quality of live. Review of the literature. Arch Intern Med. 1995;155(10):1013-22.
            13. Rosso SF, Perafán P. Validación del índice pronóstico específico de neumonía (índice de Fine) en neumonía adquirida en la comunidad en el Hospital Universitario del Valle (HUV), Cali-Colombia. Rev Colomb Neumol. 1998;10(1):9-15.
            14. Forero JC. Neumonía adquirida en comunidad en el adulto. Es hora de implementar las guías de manejo clínico institucionales. Acta Mel Col. 2013;38(4):206-7.
            15. Lim WS, Van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-82.
            16. Singer M, Deutschman CS, Seymour C, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.
            17. Gil-Bona J, Sabaté A, Miguelena Bovadilla JM, Adroer R, Koo M, Jaurrieta E. Valor de los índices de Charlson y la escala de riesgo quirúrgico en el análisis de la mortalidad operatoria. Cir Esp. 2010;88(3):174-9.
            18. Charlson ME, Charlson RE, Peterson JC, Marinopoulos S, Briggs W, Hollenberg J. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234-40.
            19. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-50.
            20. Neill AM, Martin IR, Weir R, Chereshsky A, Epton MJ, Jackson R, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax. 1996;51(10):1010-6.
            21. D’Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med. 1993;32(5):382-7.
            22. Torres OH, Muñoz J, Ruiz D, Ris J, Gich I, Coma E, et al. Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J Am Geriatr Soc. 2004;52(10):1603-9.
            23. Olmedo Samperio M, Muñoz Betegón I, Andrés del Olmo B, Demelo Rodríguez P, García Parra C, Marcelo Ayala A, et al. Validez actual del índice de Charlson para predecir la mortalidad a un año en los pacientes ingresados en medicina interna. Rev Clin Esp. 2014;214-482
            24. Baena Caparrós J, Mesalles i Sanjuan E, Arméstar Rodríguez FR, Oller Sales B. Factores pronósticos de mortalidad de la neumonía neumocócica grave en la UCI [tesis de doctorado]. [Barcelona, España]: Universitat Autònoma de Barcelona; 2011. 99 páginas.
            25. Wesemann T, Nüllmann H, Pflug M, Heppner H, Pientka L, Thiem U. Pneumonia severity, comorbidity and 1-year mortality in predominantly older adults with community-acquired pneumonia: a cohort study. BMC Infect Dis. 2015;15(1):2.
            26. Chen Y, Wang J, Guo S. Use of CRB-65 and quick Sepsis related Organ Failure Assessment to predict site of care and mortality in pneumonia patients in the emergency department: a retrospective study. Crit Care. 2016;20(1):167.
            27. Ranzani OT, Prina E, Menéndez R, Ceccato A, Cilloniz C, Méndez R, et al. New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study. Am J Respir Crit Care Med. 2017;196(10):1287-97.
            28. Tokioka F, Okamoto H, Washio Y, Yamazaki A, Ito A, Ishida T. Predictive Performance of Quick Sepsis-Related OrgaFailure Assessment for Mortality and Intensive Care Unit Admission Among Patients with Community-Acquired Pneumonia. Am J Respir Crit Care Med. 2017;195:A3952.
            29. Kim M, Lim J, Oh S. Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia. Scand J Clin Lab Invest. 2017;77(7):486-92.

            Information

            Journal history

            Keywords

            QR code

            Funding

            Support + Info: Here

             

             

            Directories and indexes

            Google Scholar profile

            Most read in the last 30 days

            Current Issue

            Sistema OJS 3.4.0.7 - Metabiblioteca |